(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Earnings Preview: Amicus Therapeutics, ANSYS, and Etsy Take Center Stage

  • February 16th, 2025
  • 37 views

On Wednesday, February 19, a series of companies are gearing up to release their financial results, including:

Amicus Therapeutics, Inc. (Nasdaq: FOLD), a biotechnology company specializing in rare and orphan diseases, will report its full-year 2024 financial results before the market opens. Market consensus points to expected earnings per share (EPS) of $0.09 on revenue totaling $147.87 million. On Friday, $FOLD closed at $9.77, up $0.13 (+1.35%).

ANSYS, Inc. (Nasdaq: ANSS), a leader in engineering simulation software, will release its fourth-quarter and full-year 2024 earnings after the market closes. The consensus estimate is EPS of $3.86, accompanied by revenue reaching $864.46 million. $ANSS closed at $338.93 on Friday,, down $0.24 (-0.07%).

Etsy, Inc. (Nasdaq: ETSY), the e-commerce platform known for handmade and vintage goods, will announce its fourth-quarter and year-end 2024 financial results before the market opens. Analysts forecast EPS of $0.94 on revenue of $861.37 million. On Friday, $ETSY closed at $57.20, reflecting an increase of $1.88 (+3.40%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13